NURIX THERAPEUTICS, INC. (NRIX) Total liabilities 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) total liabilities at each fiscal year-end, per SEC filings.
$149.4MFY2025 · since FY2019: $53.6M → $149.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $149.4M | +4.9% |
| FY2024 | $142.3M | -8.2% |
| FY2023 | $155.1M | +37.2% |
| FY2022 | $113.1M | -15.9% |
| FY2021 | $134.5M | +26.8% |
| FY2020 | $106.1M | +98.0% |
| FY2019 | $53.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice